Abstract
Objective. Inhaled nitric oxide (NO) can be delivered continuouslyor sequentially (= during inspiration) at different locations of theventilation circuit. We have tested the influence of locations, modes of NOadministration and the ratio of the inspiratory time over the respiratorycycle time (I/I + E ratio) on the accuracy of NO fractions, delivered by 2devices: Opti-NO and Flowmeter. Methods.We used a simplified lungmodel consisting of a ventilation circuit with a Y piece, a tracheal tube, a150 ml dead-space volume and a 5 liter balloon. Three fractions (3, 6, 9 ppm)were administered continuously or sequentially, in controlled volume, in 4different sites on the inspiratory branch above the Y piece:i) justafter the water trap, ii) just before the Y piece; below the Y piece:iii) just after the Y piece, iv) into the endotracheal tube. In addition,different I/I + E ratios (25, 33, 50, 80%) were studied. The delivered NOfractions were measured in the balloon by chemiluminescence (CLD 700,Ecophysics). A linear regression analysis was used to test the relationshipbetween administered and measured NO fractions for the 3 fractions (3, 6 and9 ppm) in sequential and continuous modes. Intercept values were compared tozero and slopes to the identity line. Results.When NO was administeredin the continuous mode upstream the Y piece, NO fractions measured in theballoon corresponded to the administered fractions. In contrast, below the Ypiece, the measured NO fractions were significantly lower than theadministered NO fractions. In the sequential mode, above and below the Ypiece, the delivered NO fractions were within the manufacturer's range.Conclusions.For the continuous NO delivery, locations above the Ypiece are mandatory. However, locations below the Y piece imposes a sequentialsystem, which can also be used for the sites located above the Y piece.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
REFERENCES
Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265–9269
Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature 1987; 327: 524–526
Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173–1174
Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl JMed 1993; 328: 399–405
Troncy E, Collet JP, Shapiro S et al. Should we treat acute respiratory distress syndrome with inhaled nitric oxide? Lancet 1997; 350: 111–112
Michael J, Barton R, Sa¥e J et al. Inhaled nitric oxide versus conventional therapy: Effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998; 157: 13721380
Dellinger RP, Zimmerman J, Taylor R et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Crit CareMed 1998; 26: 15–23
Wessel DL, Adatia I, Thompson JE, Hickey PR. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 1994; 22: 930938
McIntyre RC Jr, Moore FA, Moore EE, Piedalue F, Haenel JS, Fullerton DA. Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrome. J Trauma 1995; 39: 418–425
Selldén H, Winberg P, Gustafsson LE, Lundell BO, Böök K, Frostell G. Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2-kg infant. Anesthesiology 1993; 78: 577–580
Blomqvist H, Wickerts CJ, Andreen M, Ullberg U, Örtqvist A, Frostell C. Enhanced pneumonia resolution by inhalation of nitric oxide? Acta Anaesthesiol Scand 1993; 37: 110–114
Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intens Care Med 1993; 19: 443–449
Girard C, Lehot JJ, Pannetier JC, Filley S, Franch P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992; 77: 880–883
Lu Q, Mourgeon E, Law-Koune JD et al. Dose-response curves of inhaled nitric oxide with and without intravenous almitrine in nitric oxide-responding patients with acute respiratory distress syndrome. Anesthesiology 1995; 83: 929–943
Day RW, Guarin M, Lynch JM, Vernon DD, Dean JM. Inhaled nitric oxide in children with severe lung disease: Results of acute and prolonged therapy with two concentrations. Crit CareMed 1996; 24: 215–221
Beghetti M, Habre W, Friedli B, Berner M. Continuous low-dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995; 73: 65–68
Journois D, Pouard P, Mauriat P, Malhe© re T, Vouhé P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994; 107: 1129–1135
Mourgeon E, Gallart L, Rao GS et al. Distribution of inhaled nitric oxide during sequential and continuous administration into the inspiratory limb of the ventilator. Intens CareMed 1997; 23: 849–58
Chiche JD, Canivet JL, Damas P, Joris J, Lamy M. Inhaled nitric oxide for hemodynamic support after postpneumonectomyARDS. Intens CareMed 1995; 21: 675–678
Levy B, Bollaert PE, Bauer P, Nace L, Audibert G, Larcan A. Therapeutic optimization including inhaled nitric oxide in adult respiratory distress syndrome in a polyvalent intensive care unit. J Trauma 1995; 38: 370–374
Blanch L, Joseph D, Fernandez R et al. Hemodynamic and gas exchange responses to inhalation of nitric oxide in patients with acute respiratory distress syndrome and in hypoxemic patients with chronic obstructive pulmonary disease. Intens Care Med 1997; 23: 51–57
Wysocki M, Delclaux C, Roupie E et al. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bimesylate in the adult respiratory distress syndrome. Intens Care Med 1994; 20: 254–259
Rich GF, Murphy GD Jr, Roos CM, Johns RA. Inhaled nitric oxide. Selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 1993; 78: 1028–1035
Benzig A, Geiger K. Inhaled nitric oxide lowers pulmonary capillary pressure and changes longitudinal distribution of pulmonary vascular resistance in patients with acute lung injury. Acta Anesthesiol Scand 1994; 38: 640645
Gatecel C, Mebazaa A, Kong R et al. Inhaled nitric oxide improves hepatic tissue oxygenation in right ventricular failure: Value of hepatic venous oxygen saturation monitoring. Anesthesiology 1995; 82: 588–590
Fierobe L, Brunet F, Dhainaut JF et al. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. Am J Respirat Crit Care Med 1995; 151: 1414–1419
Cuthbertson BH, Dellinger P, Dyar OJ et al. UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS. Intens CareMed 1997; 23: 1212–1218
Payen D, Gatecel C, Guinard N. Inhalation of low dose of nitric oxide and IV L Arginine in ARDS: Effect of pulmonary hemodynamic and gas exchange. Barcelone: Springer International 1992; S66 (26–31October)
Rossaint R, Flake KJ, Keitel M et al. Inhaled nitric oxide in severe ARDS. Barcelone: Springer International 1992; S66 (27–31October)
Imanaka H, Hess D, Kirmse M et al. Inaccuracies of nitric oxide delivery systems during adult mechanical ventilation. Anesthesiology 1997; 86: 676–688
Ducros L, Thomazeau L, Payen D. Monitoring of expired nitric oxide. In: Hill MG, Tobin MJ, eds., Principles and practice of intensive care monitoring. 1998: 707–717
Sydow M, Bristow F, Zinserling J, Allen SJ. Variation of nitric oxide concentration during inspiration. Crit Care Med 1997; 25: 365–371
Young JD, Dyar OJ. Delivering and monitoring of inhaled nitric oxide. Intens CareMed 1996; 22: 77–86
Foubert L, Fleming B, Latimer R et al. Safety guidelines for use of nitric oxide. Lancet 1992; 339: 1615–1616
Miller OI, Celermajer DS, Dean¢eld JE, Macrae DJ. Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child Fetal Neonatal Ed 1994; 70: F47F49
Stenqvist O, Kjelltoft B, Lundin S. Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesthesiol Scand 1993; 37: 687–691
Westfelt UN, Lundin S, Stenqvist O. Safety aspects of delivery and monitoring of nitric oxide during mechanical ventilation. Acta Anaesthesiol Scand 1996; 40: 302–310
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sieffert, E., Ducros, L., Losser, MR. et al. Inhaled Nitric Oxide Fraction is Influenced by Both the Site and the Mode of Administration. J Clin Monit Comput 15, 509–517 (1999). https://doi.org/10.1023/A:1009971712989
Issue Date:
DOI: https://doi.org/10.1023/A:1009971712989